The European Medicines Agency's, or EMEA, Committee for Medicinal Products for Human Use, or CHMP, adopted one positive opinion, recommending the...
The European Medicines Agency, or EMEA, has concluded that methylphenidate-containing medicines remain suitable for the treatment of children aged...
Daiichi Sankyo Co. (4568.TO) is aiming to apply for Japanese government approval during the next fiscal year from April on its new influenza drug...
GlaxoSmithKline PLC (GSK) Wednesday said it has received approval to sell non-prescription weight-loss product Alli, a key new growth driver for...
Roche Holding AG (ROG.VX) Wednesday said it received European Union approval to sell its rheumatoid arthritis drug RoActemra, underlining the...
Swiss drugmaker Roche Holding AG (ROG.VX) said Wednesday the European Commission has approved RoACTEMRA, or tocilizumab, known as Actemra outside...
By Elena Berton Of DOW JONES NEWSWIRES TAKING THE PULSE: European pharmaceutical companies are expected once again to show they are relatively...
Genentech Inc.'s (DNA) fourth-quarter profit rose 47% on strong sales of its cancer drugs, but it gave a disappointing earnings outlook as it...
Genentech Inc.'s (DNA) fourth-quarter profit rose 47% on strong sales of its cancer drugs, but it gave a disappointing 2009 earnings outlook...
Genentech Inc.'s (DNA) fourth-quarter net income surged 47% on surging sales of most of its U.S. products, as the biotechnology giant issued a...
Swiss drugmaker Roche Holding AG (ROG.VX) plans to reduce headcount at its production sites by 780 positions over the next two to three years...
Swiss drugmaker Roche Holding AG (RHHBY) plans to reduce headcount at its production sites by 780 positions over the next two to three years...
(Updates with Elan CEO comments beginning in the fifth paragraph) By Ragnhild Kjetland and Elena Berton Of DOW JONES NEWSWIRES Irish drug-maker...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.